Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03526419 · ClinicalTrials.gov registry record
Exparel PK and Breast Milk Excretion
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 30
- Enrollment target
NCT03526419 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 30 participants.
The verdict
NCT03526419 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Investigate the pharmacokinetics of Liposomal Bupivacaine and its excretion in breast milk in patients undergoing TAP block after their scheduled C -section delivery
Interventions
- DRUG Bupivacaine liposome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2019-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03526419
The ClinicalTrials.gov registry entry for NCT03526419 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bupivacaine liposome is the first listed.
NCT03526419 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03526419 about?
NCT03526419 is a clinical study titled "Exparel PK and Breast Milk Excretion". Investigate the pharmacokinetics of Liposomal Bupivacaine and its excretion in breast milk in patients undergoing TAP block after their scheduled C -section delivery
What is the current status of trial NCT03526419?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2019-02-01. Estimated completion is 2019-09-01.
What interventions are being tested in trial NCT03526419?
The interventions under investigation include: Bupivacaine liposome (DRUG).
Who is sponsoring clinical trial NCT03526419?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.